S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|The Medicines Company Reports Second Quarter and First Half 2014 Results|
|The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission|
|The Medicines Company to Present New Data from its Infectious Disease Portfolio at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)|
|The Medicines Company and Alnylam Pharmaceuticals to Host RNAi Roundtable Webcast “ALN-PCSsc for the Treatment of Hypercholesterolemia”|
|The Medicines Company to Announce Second Quarter and First Half 2014 Financial Results on Wednesday, July 23, 2014|
|The Medicines Company to Review ORBACTIVTM (oritavancin) Launch Readiness on Tuesday, September 16, 2014|
|The Medicines Company to Host Infectious Disease Care Investor and Analyst Meeting on September 24, 2014|
|Fourth Annual Stem Cell Meeting on the Mesa Partnering Forum Announces Presenting Companies|
|Alnylam Pharmaceuticals Reports Second Quarter 2014 Financial Results and Highlights Recent Period Activities|
|Macrocure Ltd. Announces Second Quarter 2014 Financial Results Date and Conference Call|
Click above to view more mutual fund data and stats for mdco - The Medicines Company.